Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model.

Maria Siopi; Eleftheria Mavridou; Johan W Mouton; Paul E Verweij; Loukia Zerva; Joseph Meletiadis

首页> 外文期刊>The Journal of Antimicrobial Chemotherapy >Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model.

【24h】

Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model.

机译：在体外药代动力学/药效学模型中，伏立康唑和烟曲霉的药敏监测的敏感性极限和目标值。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

These susceptibility breakpoints and target values for therapeutic drug monitoring could be used to optimize voriconazole therapy against A. fumigatus.

机译：这些用于治疗药物监测的敏感性临界点和目标值可用于优化伏立康唑对烟曲霉的治疗。

著录项

来源
《The Journal of Antimicrobial Chemotherapy》 |2014年第6期|共9页
作者
Maria Siopi; Eleftheria Mavridou; Johan W Mouton; Paul E Verweij; Loukia Zerva; Joseph Meletiadis;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model. [J] . Maria Siopi, Eleftheria Mavridou, Johan W Mouton, The Journal of Antimicrobial Chemotherapy . 2014,第6期

机译：在体外药代动力学/药效学模型中，伏立康唑和烟曲霉的药敏监测的敏感性极限和目标值。
2. Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model-authors' response [J] . Siopi Maria, Mavridou Eleftheria, Mouton Johan W., The Journal of Antimicrobial Chemotherapy . 2015,第2期

机译：在体外药代动力学/药效学模型作者的反应中，伏立康唑和烟曲霉的药敏监测的敏感性极限和目标值
3. Comment on: Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model [J] . Denning David W., Ghnan Nesrin, Kwizera Richard, The Journal of Antimicrobial Chemotherapy . 2015,第2期

机译：评论：在体外药代动力学/药效学模型中伏立康唑和烟曲霉的治疗性药物监测的敏感性临界点和目标值
4. PHARMACOKINETIC AND PHARMACODYNAMIC MODELS FOR THE STUDY OF DRUGS OF ABUSE AND THERAPEUTIC MEDICATIONS IN THE EQUINE RACING INDUSTRY [C] . . 2005

机译：马术竞赛中药物滥用和治疗药物的药代动力学和药代动力学模型
5. Effect of Cytochrome P450 2C19 Genotyping and Therapeutic Drug Monitoring on Efficacy and Toxicity of Voriconazole Therapy [D] . Lee, Joseph Zhuo Lun. 2016

机译：细胞色素P450 2C19基因分型和治疗药物监测对伏立康唑治疗的疗效和毒性的影响
6. Susceptibility Breakpoints for Amphotericin B and Aspergillus Species in an In Vitro Pharmacokinetic-Pharmacodynamic Model Simulating Free-Drug Concentrations in Human Serum [O] . A. Elefanti, J. W. Mouton, P. E. Verweij, 2014

机译：两性霉素B和曲霉菌种在模拟人体血清中自由药物浓度的体外药代动力学-药效学模型中的敏感性断点
7. Comment on: Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model [O] . D. W. Denning, N. Ghnan, R. Kwizera, 2014

机译：评论：在体外药代动力学/药效学模型中voriconazole和曲霉病毒测量治疗药物监测的易感性断裂点和目标值

Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model.

摘要

著录项

相似文献

相关主题

期刊订阅